StockData
GT Biopharma, Inc. logo

GT Biopharma, Inc. (GTBP) stock

GTBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30
$3.18−0.35 (-10.04%)

Close on Nov 17, 2026Market cap $143.45MP/E –Yield –

GT Biopharma operating margin

Operating margin is operating income as a percentage of revenue.

For fiscal 2015 it was -33063.0%, against -3927.9% the year before. The highest annual figure on record is -215.5% in fiscal 2013.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2015Dec 31, 2015-33063.0%−29135.1
FY2014Dec 31, 2014-3927.9%−3712.4
FY2013Dec 31, 2013-215.5%+812.0
FY2012Dec 31, 2012-1027.5%+14080.2
FY2011Dec 31, 2011-15107.7%+7592.3
FY2010Dec 31, 2010-22700.0%–

More GT Biopharma figures

See a number that looks wrong?